Training future leaders in neural interfacing technology
Integrative Training in Neural Interfacing
['FUNDING_TRAINING'] · CARNEGIE-MELLON UNIVERSITY · NIH-10894258
This program is designed to help doctoral students learn how to create technologies that connect with the brain, so they can better understand how it works and find new ways to help patients with brain-related issues.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CARNEGIE-MELLON UNIVERSITY (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-10894258 on ClinicalTrials.gov |
What this research studies
This program aims to train doctoral students in neural interfacing, focusing on the intersection of engineering and brain science. Students will learn to develop technologies that can sense, model, and modulate brain activity, enhancing our understanding of brain function and dysfunction. The training includes hands-on experience in applying these technologies in real-world biological settings, ultimately aiming for clinical applications that could improve patient outcomes. The program emphasizes interdisciplinary education to foster innovation in this emerging field.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with neurological disorders or those interested in cutting-edge neural interfacing technologies.
Not a fit: Patients who are not affected by neurological conditions or who do not have an interest in neural interfacing technologies may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in neural interfacing technologies that improve the diagnosis and treatment of neurological conditions.
How similar studies have performed: Other research in neural interfacing has shown promise in advancing our understanding of brain function and developing innovative technologies, indicating that this approach has potential for success.
Where this research is happening
PITTSBURGH, UNITED STATES
- CARNEGIE-MELLON UNIVERSITY — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HE, BIN — CARNEGIE-MELLON UNIVERSITY
- Study coordinator: HE, BIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.